These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35595169)

  • 61. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A dynamically coupled allosteric network underlies binding cooperativity in Src kinase.
    Foda ZH; Shan Y; Kim ET; Shaw DE; Seeliger MA
    Nat Commun; 2015 Jan; 6():5939. PubMed ID: 25600932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.
    Inan T; Flinko R; Lewis GK; MacKerell AD; Kurkcuoglu O
    J Phys Chem B; 2024 May; 128(21):5157-5174. PubMed ID: 38647430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.
    Meng Y; Pond MP; Roux B
    Acc Chem Res; 2017 May; 50(5):1193-1201. PubMed ID: 28426203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
    James KA; Verkhivker GM
    PLoS One; 2014; 9(11):e113488. PubMed ID: 25427151
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Approach in Improving Potency and Selectivity of Kinase Inhibitors: Allosteric Kinase Inhibitors.
    Wei S; Zhao T; Wang J; Zhai X
    Mini Rev Med Chem; 2021; 21(8):991-1003. PubMed ID: 33355051
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allosteric Modulators of Protein-Protein Interactions (PPIs).
    Ni D; Liu N; Sheng C
    Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Substrate activity screening with kinases: discovery of small-molecule substrate-competitive c-Src inhibitors.
    Breen ME; Steffey ME; Lachacz EJ; Kwarcinski FE; Fox CC; Soellner MB
    Angew Chem Int Ed Engl; 2014 Jul; 53(27):7010-3. PubMed ID: 24797781
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies.
    Zhou Y; Zhang N; Qi X; Tang S; Sun G; Zhao L; Zhong R; Peng Y
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301250
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
    Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
    Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening.
    Zhou Q; Guo W; Dai A; Cai X; Vass M; de Graaf C; Shui W; Zhao S; Yang D; Wang MW
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34201418
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of allosteric kinase inhibitors by displacement of active site probes.
    Lebakken CS; Reichling LJ; Ellefson JM; Riddle SM
    J Biomol Screen; 2012 Jul; 17(6):813-21. PubMed ID: 22453235
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
    Panicker RC; Coyne AG; Srinivasan R
    Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
    Cowan-Jacob SW; Jahnke W; Knapp S
    Future Med Chem; 2014 Apr; 6(5):541-61. PubMed ID: 24649957
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors.
    Zhou S; Li Y; Hou T
    J Chem Inf Model; 2013 Apr; 53(4):982-96. PubMed ID: 23506306
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advances in NMR Methods to Identify Allosteric Sites and Allosteric Ligands.
    Abdelkarim H; Hitchinson B; Banerjee A; Gaponenko V
    Adv Exp Med Biol; 2019; 1163():171-186. PubMed ID: 31707704
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Principles of Kinase Allosteric Inhibition and Pocket Validation.
    Pan Y; Mader MM
    J Med Chem; 2022 Apr; 65(7):5288-5299. PubMed ID: 35312319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.